Drug Evaluation Central & Peripheral Nervous Systems: Remifentanil: an opioid metabolised by esterases

References

• FELDMAN PL, JAMES MK, BRACICEEN MF et al.: Design, •synthesis, and pharmacological evaluation of ul-trashort- to long-acting opiold analgetics. J. Med. Chem. (1991) 34:2202–2208.
   PubMed Web of Science ®Google Scholar
• WESTMORELAND CL, HOKE JF, SEBEL PS, HUG CC, MUIR ••KT:
   Google Scholar
• Pharmacoldnetics of remifentanil (6187084B) and its major metabolite (6190291) in patients undergoing elective inpatient surgery. Anesthesiology (1993) 79:893–903.
   PubMed Web of Science ®Google Scholar
• STILLER IlL, DAVIS PJ, MCGOWAN FX et al.: Its vitro metabolism of remifentanil: the effects of pseudocholi-nesterase deficiency. Anesthesiology (1995) 83:A381.
   Web of Science ®Google Scholar
• SELINGER K, NATION RL, SMITH GA: Enzymatic and chemical hydrolysis of remifentaniL Anesthesiology (1995) 83:A385. DUTHIE DJR, MUIR Kr, BADDOO HHK et al.: Remifentanil Is not metabolised by the lung. Anesthesiology (1995) 83A324.
   Google Scholar
• JAMES MK, FELDMAN PL, SCHUSTER SV et al.: Opioid •receptor activity of 6I87084B, a novel ultra-short acting 35. analgesic, in isolated tissues. J. Pharmacol. Exp. Ther. (1991) 259:712–718.
   PubMed Web of Science ®Google Scholar
• CUNNINGHAM FE, HOKE JF, MUIR KT, JAMES MK, HOFF- •MAN WE: Pharmacokinetic/pharmacodynamic evalu-ation of remifentanil, GR90291, and alfentanil. Anesthesiology (1995) 83:A376.
   Web of Science ®Google Scholar
• SELIGER K, LANZO C, SEKUF A: Determination of re-mifentanil in human and dog blood by HPLC with UV detection. J. Pharm. Biomed. Anal. (1994) 12:243–248.
   PubMed Web of Science ®Google Scholar
• GROSSE CM, DAVIS IM, ARRENDALE RE, JERSEY J, AMIN J: •Determination of remifentanil in human blood by liq-uid-liquid extraction and capillary GC/HRMS/SIM using a deuterated internal standard. J. Pharm. Biomed. Anal. (1994) 12:195–203.
   PubMed Web of Science ®Google Scholar
• SEBEL PS, HOKE JF, WESTMORELAND C etal.: Histamine concentrations and hemodynamic responses after re-mifentaniL Anesth. Analg. (1995) 80:990–993.
   Google Scholar
• GLASS PSA, HARDMAN D, KAMIYAMA Y etal.: Preliminary pharmacokinetics and pharmacodynamics of an ultra-short-acting opioid: remifentanil (6187084B). Anesth. Analg. (1993) 77:1031–40.
   Google Scholar
• EGAN TD, LEMMENS HJM, FISET P etal.: The pharntacok- •inetics of the new short acting opioid remifentanil(GI87084B) in healthy adult male volunteers. Anesthesi-ology (1993) 79:881–892.
   Google Scholar
• EGAN TD, MINTO CF, HERMANN DJ et al.: Remifentanil •versus alfentaniL Comparative pharmacokinetics andpharmacodyqunies in healthy adult male volunteers. Anesthesiology (1996) 84:821–833.
   PubMed Web of Science ®Google Scholar
• SHAFER SL, VARVEL JR: Pharmacokinetics, pharmacody- •narnies, and rational opiokl selection. Anesthesiology(1991) 74:53–63.
   PubMed Web of Science ®Google Scholar
• HUGHES MA, GLASS PSA, JACOBS JR: Context-sensitive •half-time in multicompartment pharntacokinetic mod-els for intravenous anesthetic drugs. Anesthesiology (1992) 76:334–341.
   PubMed Web of Science ®Google Scholar
• KAPILA A, GLASS PSA, JACOBS JR etal.: Measured context- sensitive half-times of remifentanil and alfentaniL An-esthesiology (1995) 83:968–975.
   Google Scholar
• EGAN ID, GUPTA SK, SPERRY RJ etal.: The pharmacolti-netics of retnifentanil in obese versus lean elective surgery patients. Anesth. Analg. (1996) 82:S100.
   Google Scholar
• miNTo CF, SCHNEIDER TW, EGAN TD etal.: The influence of age and gender on the pharmacokinetics and phar-macodynamics of remifentaniL L Model development. Anesthesiology (1996). In press.
   Google Scholar
• DERSHWITZ M, HOKE JF, ROSOW CE etal.: Pharrnacoki- •netics and pharmacodynamics of remifentanil in vol- unteer subjects with severe liver disease. Anesthesiology (1996) 84:812–820.
   Google Scholar
• NAVAPURKAR VU, ARCHERS, FRAZER NM et al.: Pharma-cokinetics of remifentanil during hepatic transplanta-tion. Anesthesiology (1995) 83:A382.
   PubMedGoogle Scholar
• SHLUGMAN D, DUFORE S, DERSHWITZ M et al.: Respira-tory effects of remifentanil in subjects with severe renal Impairment compared to matched controls. Anesthesi-ology (1994) 81:A1417.
   Web of Science ®Google Scholar
• HOKE JF, MUIR KT, GLASS PSA et al.: Pharmacokinetics of remifentanil and its metabolite (GR90291) in subjects with renal disease. Clin. Pharm. Ther. (1995) 57:148.
   Web of Science ®Google Scholar
• DAVIS PJ, ROSS A, STILLER EL etal.: Pharmacokinetics ofremifentanil in anesthetized children 2–12 years of age. Anesth. Analg. (1995) 80:S93.
   Google Scholar
• JOSHI P, JHAVERI R, BAUNIAN V etal.: Comparative trialof remifentanil and alfentanil for anesthesia induction. Anesthesiology (1993) 79:A379.
   Google Scholar
• FRAGEN RJ, RANDEL GI, LIBROJO ES, CLARICE MY, JAMER- SON BD: The interaction of remifentanil and propofol to prevent response to tracheal intubation and the start of surgery for outpatient knee arthroscopy. Anesthesiol-ogy (1994) 81:A376.
   PubMedGoogle Scholar
• PEACOCK J, REILLY C, LUNTLEY J etal.: Remifentanil in combination with propofol for spontaneous ventila-tion anesthesia. Anesthesiology (1995) 83:A35.
   Google Scholar
• KAPILA A, LANG E, GLASS P et al.: MAC reduction of isoflurane byremifentaniL Anesthesiology (1994) 81:A378.
   Web of Science ®Google Scholar
• MUNDAY IT, WARD PM, SOROOSHIAN S etal.: Interaction between remifentanil and isofturane in spontaneously breathing patients during ambulatory surgery. Anesthe-siology (1995) 83:A23.
   Google Scholar
• HOWLE MB, KELLY WB, POREMBKA DT et al.: Catecho-'amine response during CABG with remffentann anes-thesia. Anesth. Analg. (1996) 82:S189.
   Google Scholar
• M1CHELSEN LG, HUG CC, WODA RP eta!,: Early extuba-lion of CABG patients after remifentanil anesthesia. Anesth. Analg. (1986) 82:S314.
   Google Scholar
• KALLAR SK, HURT TW, WETCHLER BV, SHAW DL, JAMER-SON B: A single blind, comparative study of the safety and efficacy of remifentanil and alfentanil for outpa-tient anesthesia. Anesthesiology (1994) 81:A32
   Web of Science ®Google Scholar
• CHUNG F, SKINNER EP, JAMERSON BD, REESE PR: Recov-ery and reasons for discharge delay after remifentanil vs. alfentanil in outpatient surgery. Anesth. Analg. (1996) 82:S65.
   Google Scholar
• PHILIP BK, SCUDERI PE, CHUNG F etal.: Comparison ofremffentanil/propofol to alfentanil/propofol for la-paroscopic outpatient surgery. Anesthesiology (1995) 83:A3.
   Google Scholar
• MONK TG, BATENHORST RL, FOLGER WH et al.: A com-parison of remifentanit and alfentanil during nitrous-narcotic anesthesia. Anesth. Analg. (1994) 78:S293.
   PubMedGoogle Scholar
• SUNG YF, STULTING RD, BEATTE CD, STEAD S, JAMERSON BD: Intraocular pressure effects of remifentanil (6187084B) and alfentaniL Anesthesiology (1994) 81:A35.
   Google Scholar
• SMITH I, AVRAMOV, WHITE PF: Remifentanil versus propofol for monitored anesthesia care - effects on ventilation. Anesthesiology (1995) 83:A4.
   Web of Science ®Google Scholar
• SMITH I, AVRAMOV M, WHITE PF: ReroMentanil versus propofol for monitored anesthesia care in the ambula-tory setting. Anesthesiology (1995) 83:A5.
   Web of Science ®Google Scholar
• DESMONTS JM, ATTKENHEAD AR, CAMU F etal.: Compari- son of remifentanil and propofol as adjunct therapy during regional anesthesia. Anesthesiology (1995) 83:A857.
   Google Scholar
• MINGUS M, ROSENBLATT M, GAINSBURG D etal.: Com- parison of remifentanil and propofol as adjuncts to peripheral regional anesthesia for ambulatory surgery. Anesth. Analg. (1996) 82:S319. • • • •
   Google Scholar
• MONK TG, PULLEY DD, JENKINS WL et al.: Comparisonof remifentanil and propofol as adjuncts to spinal anesthesia. Anesth. Analg. (1996) 82:S321.
   PubMedGoogle Scholar
• wrricowsKi T, AZAD SS, LESSIN J et al.: Post-op analgesiawith remifentanib dosage and side-effects. Anesth. Analg. (1995) 80:S554.
   Google Scholar
• YARMUSH J, D'ANGELO R, O'LEARY C et al.: Remifentanilvs. morphine for acute postoperative analgesia. Anesth. Analg. (1996) 82:S504.
   Google Scholar
• DERSHWITZ M, RANDEL GI, ROSOW CE et al.: Initial •clinical experience with remifentanil, a new opioidmetabolized by esterases. Anesth. Analg. (1995) 81:619–623.
   PubMed Web of Science ®Google Scholar
• HOGUE CW, BOWDLE TA, O'LEARY C et al.: A multicenterevaluation of total intravenous anesthesia with re-mifentanil and propofol for elective inpatient surgery. Anesth. Analg. (1996) 83:279–285.
   Google Scholar
• MICHELSEN LG, SALMENPERA M, HUG CC, Jr., SZLAM F, VAN DER MEER D: Anesthetic potency of remifentanil In dogs. Anesthesiology (1996) 84:865–872.
   PubMed Web of Science ®Google Scholar
• WARNER DS, HINDMAN BJ, TODD MM et al.: Intracranial pressure and hemodynamic effects of remffentanil ver-sus alfentanil in patients undergoing supratentorial craniotomy. Anesth. Analg. (1996) 83:348–353.
   PubMed Web of Science ®Google Scholar
• ROSOW CE: Remifentanil: a unique opioid analgesic [Editorial]. Anesthesiology (1993) 79:875–876.
   PubMed Web of Science ®Google Scholar
• BUERKLE H, YAKSH TL: Comparison of the spinal actions •of the µ-opioid remifentanil with alfentanil and mor-phine in the rat. Anesthesiology (1996) 84:94–102.
   PubMed Web of Science ®Google Scholar
• BUERKLE H, YAKSH TL: Continuous intrathecal admini-stration of short-lasting p. opioids remifentanil and alfentanil in the rat. Anesthesiology (1996) 84:926–935.
   Google Scholar
• SCOTT JC, STANSKI DR: Decreased fentanyl and alfen-tanil dose requirements with age. A simultaneous phar-macokinetic and pharmacodynamic evaluation. J. Pharmacol. Esp. Tiler. (1987) 240:159–166.
   Web of Science ®Google Scholar
• HUDSON RJ, BERGSTROM RG, THOMSON IR et al.: Phar- macokinetics of sufentanil in patients undergoing ab-dominal aortic surgery. Anesthesiology (1989) 70:426–431.
   PubMed Web of Science ®Google Scholar
• DERSHWITZ M, ROSOW CE: Remifentanil a truly-short-acting opioid. Seminars in Anesthesia (1996) 15:88–96.
   Google Scholar
• DERSHWITZ M, ROSOW CE: The pharmacokinetics and •pharmacodynamics of remifentanil in volunteers with severe hepatic or renal dysfunction. J. Clin. Anesth. (1996) 8:88S–90S.
   Google Scholar